H35.329

Clinical Causes: Aging: The primary risk factor, as the disease mainly affects individuals over 50 years old. Genetic predisposition: Family history can increase the risk. Cardiovascular disease: Conditions like hypertension and high cholesterol may contribute. Lifestyle factors: Smoking, poor diet, and lack of exercise have been linked to increased risk. Exposure to sunlight: Long-term UV exposure might play a role. Other factors: Obesity and certain ethnic backgrounds may have a higher susceptibility.

Key Symptoms: Sudden or gradual loss of central vision. Distorted vision, where straight lines appear wavy. Dark or empty areas in the central visual field. Difficulty recognizing faces or reading small print. Changes in color perception.

Diagnosis Path: Diagnosis typically involves a comprehensive eye exam, including visual acuity testing and dilated eye examination. Additional assessments may include optical coherence tomography (OCT), fluorescein angiography, and fundus photography to evaluate retinal changes and the presence of abnormal blood vessels characteristic of exudative AMD.

Treatment Protocols: While there is no cure for age-related macular degeneration, several treatment options aim to slow or halt disease progression. For exudative AMD, treatments focus on controlling abnormal blood vessel growth and leakage. These may include: - Anti-vascular endothelial growth factor (anti-VEGF) injections to reduce abnormal blood vessel formation. - Laser therapy to destroy leaking blood vessels. - Photodynamic therapy using a light-activated drug to target abnormal vessels. - Nutritional supplements containing antioxidants and zinc, which may slow progression. Regular monitoring and prompt treatment can help preserve vision and improve quality of life for affected individuals.